Dataset opportunity
Endoquestrobotics — 医疗影像数据集机会
由Endoquestrobotics持有的中等规模医疗影像数据集，可用于诊断AI和计算机视觉。
Score
70
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
数据共享协议
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market
全球医疗影像AI市场 = 2024年17亿美元，复合年增长率25.8% (来源: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE1LDw2f6kiIeYKGL2vHN8kWvNVjuxkc93utfn7deM4Evmq-IvqcRNm3fSVshoRnYGmzdEphsHNapGiBojziak2EcxElBjUt9J6WWHDFuQRHdyVoNeJxMtlHImHsUMizBP-911iw-EAaSTE1gamdQJstg==)
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-06-04
Can surgical robots fly? SS Innovations discusses challenges, solutions
therobotreport.com ↗ - 📰press2026-06-04
Diabetes tech companies are racing toward ‘fully closed loop’ devices. But automation comes with trade-offs.
medtechdive.com ↗ - 📰press2026-06-04
Medtronic seeks clearance for Hugo surgical robot in more indications
medtechdive.com ↗ - 📰press2026-06-03
Edwards gets FDA approval for surgical tricuspid valve
medtechdive.com ↗ - 📰press2026-06-03
MiniMed expands Abbott partnership to add dual glucose-ketone sensor
medtechdive.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- 📣Press / announcement
与NVIDIA合作提供数据服务和AI部署
source ↗
Profile
Dataset profile
Type
医疗影像数据集
Modality
图像
Sector
医疗保健
Volume
中等
Freshness
实时
Rarity
高（专有）
Accessibility
受限
Legal
公司所有 — GDPR敏感（PII审查）
Buyer persona
医疗AI和诊断影像公司
Endoquestrobotics拥有一个医学影像数据集（图像模态），其中包含丰富的事件流、物联网数据和医疗记录，使其非常适合诊断AI应用。这个全面的数据集允许训练先进的AI模型，以检测细微异常，提高诊断准确性，并增强治疗规划，解决了AI开发中对高质量、多样化医疗数据的关键需求。
尽管由于产品仍在开发中，需要FDA批准才能在美国商业销售，并且包含来自临床试验的敏感患者健康信息，导致访问复杂性，但该数据仍然具有极高的价值。全球医学影像AI市场直接受益于此类数据集，预计到2034年将达到168.8亿美元，复合年增长率（CAGR）为25.8%，这突显了这种稀有而丰富数据的巨大商业价值。与NVIDIA在数据服务和AI部署方面的合作进一步表明了未来内部数据货币化和在快速增长的市场中利用这一资产的战略意图。⚠ 尽职调查（有价值的数据，可协商访问）：产品正在开发中，尚未商业化；需要FDA批准才能在美国商业销售；来自临床试验的数据涉及敏感患者健康信息；与NVIDIA在数据服务和AI部署方面的合作表明未来可能进行内部数据货币化/使用。· 企业：独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据共同证明Endoquestrobotics拥有一个独特且专有的数据集，源于其先进的机器人手术系统开发和临床试验。具体而言，该数据包括来自一项关键的FDA批准的结直肠临床研究的医学影像，直接满足了预计到2024年将达到17亿美元的诊断AI市场的关键需求。这种临床影像与来自其机器人平台的丰富时间序列操作和事件数据的罕见组合，为寻求在内窥镜手术及其他领域开发尖端解决方案的医疗AI和诊断影像公司提供了无与伦比的洞察。医学影像AI市场25.8%的快速复合年增长率（CAGR）进一步提升了其相关性，使其成为一项及时且具有战略意义的收购。
See dimension details ↓- Dataset Specificity90
主导的'医疗记录'，医疗保健领域，3种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3个证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
实时/流式
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
适用于诊断AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
诊断AI市场严重依赖医学影像数据集，预计从2026年到2034年将以46.06%的复合年增长率（CAGR）增长，到2034年达到2096.3亿美元。
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/受监管
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
高难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3种证据类型，3个命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
所有权=自有，许可=GDPR敏感
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1个数据需求信号（1种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高，5个近期外部信号 — 超出已变现的专有数据
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ 良好目标 — Endoquest Robotics是一家私营中小企业，正在开发一种机器人手术系统，其操作使用将产生有价值的医学影像和传感器数据作为副产品，并且他们目前不将此数据作为核心产品出售。
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
IoT / sensor data
此证据证实了时间序列数据的可用性，详细说明了EndoQuest Robotics柔性腔内机器人手术系统的操作性能和导航，为AI驱动的优化提供了设备机械和实际使用情况的见解。
Medical records / imaging
这一关键证据表明，该医学影像数据集来源于美国FDA批准的结直肠临床研究，该研究评估了其机器人系统在内镜黏膜下剥离术（ESD）中的安全性和性能，为诊断AI开发提供了高价值数据。
Event streams
这种数据类型揭示了与机器人系统的传感器处理、3D可视化和精确运动控制相关的时间同步事件流，展示了一个复杂的数据捕获环境，非常适合训练AI模型进行实时机器人操作和控制。
Marketplace
Dataset details
Geographic coverage
Global
Time range
Real-time (specific study period not defined, assumed ongoing/recent)
Update frequency
Real-time
Delivery
API/Secure Download
Formats
Image (DICOM/NIfTI), Event Streams
License
One-time license for Diagnostic AI development and commercialization, subject to regulatory approvals and PII handling agreements.
Personal data
Contains PII
Indicative estimate, derived from public signals — not a quote, not contractual, and not agreed with the company. Is this your company? Correct it.
This dataset's value is driven by its high rarity, proprietary nature from a robotic surgery system, and direct application in the rapidly growing Diagnostic AI market. The moderate volume and real-time freshness are key, though access complexity and PII risk temper the upper valuation.
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Endoquestrobotics Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in Medical Imaging market = $1.70 Billion in 2024, CAGR 25.8% (source: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQE1LDw2f6kiIeYKGL2vHN8kWvNVjuxkc93utfn7deM4Evmq-IvqcRNm3fSVshoRnYGmzdEphsHNapGiBojziak2EcxElBjUt9J6WWHDFuQRHdyVoNeJxMtlHImHsUMizBP-911iw-EAaSTE1gamdQJstg==). Investment score 70.0/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Smart Energies — 维护日志数据集机会
View opportunity →移动出行Suivideflotte — 移动遥测数据集机会
View opportunity →其他Iel Energie — 传感器遥测数据集机会
View opportunity →